Vatelizumab, CAS [[1238217-55-4]]

Produktübersicht

• Artikelname: Vatelizumab, CAS [[1238217-55-4]]
• Artikelnummer: TGM-T80875
• Hersteller Artikelnummer: T80875
• Alternativnummer: TGM-T80875-1MG,TGM-T80875-5MG,TGM-T80875-10MG,TGM-T80875-25MG,TGM-T80875-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: SAR 339658 , TMC-2003 , GBR 500 , CHR1103 , GBR500 , CHR-1103

Produktbeschreibung

Vatelizumab is a humanised monoclonal antibody targeting Integrin alpha2beta1 (very late antigen 2, VLA-2, CD49b), which enhances the frequency of regulatory T cells via the p38 MAPK signalling pathway and can be used for research into multiple sclerosis.

Produkteigenschaften

• Reinheit: 99.54%
• CAS Nummer: [1238217-55-4]
• Target-Kategorie: Integrin